Q1 2024 Milestone Scientific Inc Earnings Call Transcript
Key Points
- E-commerce sales increased by 31% over the same period last year, reflecting a successful shift to a direct sales model.
- Gross margin improved to 74.5% in Q1 2024 from 72.7% in Q1 2023, indicating better profitability per unit sold.
- The direct sales model has enhanced customer relationships, leading to potential repeat orders and improved customer service.
- Significant progress in the medical segment, particularly with the CompuFlo technology being adopted by new pain management clinics.
- Strong balance sheet with $5 million in cash and cash equivalents, and no long-term debt, providing financial stability.
- Overall revenue declined to $2.2 million in Q1 2024 from $2.6 million in Q1 2023, indicating a drop in sales performance.
- International sales decreased by $274,000 compared to the previous year, showing challenges in global markets.
- The company recorded no revenue from US distributors due to the strategic shift to direct sales, which might limit market reach.
- Operating losses increased to $1.5 million in Q1 2024 from $1.3 million in Q1 2023, suggesting rising operational costs.
- Withdrawal from the Chinese market until conditions improve, potentially missing out on revenue opportunities in a major market.
Good morning, everyone, and welcome to the Milestone Scientific Incorporated first quarter 2024 financial results and business update conference call. (Operator Instructions) Please note this conference is being recorded.
I will now turn the conference over to your host, David Waldman, Crescendo Communications, the floor is yours.
Good morning and thank you for joining Milestone Scientific's first quarter 2024 financial results conference call. On the call with us today are in Adriaan Haverhals, Chief Executive Officer; and Keisha Harcum, Vice President Finance of Milestone Scientific.
The Company issued a press release this morning containing first quarter 2024 financial results was also posted on the company's website. If you have any questions after the call would like any additional information about the Company, please contact Crescendo Communications at 2126711020Company's Management will now provide prepared remarks reviewing the financial and operational results for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
